Terms: = Kidney tumors AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Treatment
26 results:
1. Targeted α-Therapy Using
Ertveldt T; Krasniqi A; Ceuppens H; Puttemans J; Dekempeneer Y; Jonghe K; Mey W; Lecocq Q; Vlaeminck Y; Awad RM; Goyvaerts C; Veirman K; Morgenstern A; Bruchertseifer F; Keyaerts M; Devoogdt N; D'Huyvetter M; Breckpot K
J Nucl Med; 2023 May; 64(5):751-758. PubMed ID: 37055223
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of tert-butyl ester and ethyl ester prodrugs of L-γ-methyleneglutamic acid amides for cancer.
Khan MIH; Mahdi F; Penfornis P; Akins NS; Hossain MI; Kim SJ; Sulochana SP; Adam AT; Tran TD; Tan C; Paolo Claudio P; Paris JJ; Le HV
Bioorg Med Chem; 2023 Jan; 78():117137. PubMed ID: 36603398
[TBL] [Abstract] [Full Text] [Related]
3. Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib.
Volta AD; Delbarba A; Valcamonico F; Cappelli C; Caramella I; Bergamini M; Ferlin A; Berruti A
In Vivo; 2023; 37(1):410-416. PubMed ID: 36593059
[TBL] [Abstract] [Full Text] [Related]
4. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract] [Full Text] [Related]
5. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
Murugan P; Jia L; Dinatale RG; Assel M; Benfante N; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Hakimi AA; Russo P; Chen YB; Tickoo SK; Reuter VE
Mod Pathol; 2022 Jun; 35(6):825-835. PubMed ID: 34949764
[TBL] [Abstract] [Full Text] [Related]
6. Molecular Characterization of Muellerian tumors of the Urinary Tract.
Ortiz-Brüchle N; Wucherpfennig S; Rose M; Garczyk S; Bertz S; Hartmann A; Reis H; Szarvas T; Kiss A; Bremmer F; Golz R; Knüchel R; Gaisa NT
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200508
[TBL] [Abstract] [Full Text] [Related]
7. A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals.
Kalidindi TM; Lee SG; Jou K; Chakraborty G; Skafida M; Tagawa ST; Bander NH; Schoder H; Bodei L; Pandit-Taskar N; Lewis JS; Larson SM; Osborne JR; Pillarsetty NVK
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2642-2651. PubMed ID: 33495926
[TBL] [Abstract] [Full Text] [Related]
8. TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Schmiester M; Dolnik A; Kornak U; Pfitzner B; Hummel M; Treue D; Hartmann A; Agaimy A; Weyerer V; Lekaj A; Brakemeier S; Peters R; Öllinger R; Märdian S; Bullinger L; Striefler JK; Flörcken A
J Pathol Clin Res; 2021 Jan; 7(1):3-9. PubMed ID: 33180365
[TBL] [Abstract] [Full Text] [Related]
9. Association of body mass index with toxicity and survival in pediatric patients treated with cisplatin-containing regimens.
Bhandari R; Scott E; Yeh MY; Wong K; Rushing T; Huh W; Orgel E
Pediatr Hematol Oncol; 2021 Apr; 38(3):239-250. PubMed ID: 33170064
[TBL] [Abstract] [Full Text] [Related]
10. Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis.
Dizman N; Lyou Y; Salgia N; Bergerot PG; Hsu J; Enriquez D; Izatt T; Trent JM; Byron S; Pal S
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32661119
[TBL] [Abstract] [Full Text] [Related]
11. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E
Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885
[TBL] [Abstract] [Full Text] [Related]
12. Berberine associated photodynamic therapy promotes autophagy and apoptosis via ROS generation in renal carcinoma cells.
Lopes TZ; de Moraes FR; Tedesco AC; Arni RK; Rahal P; Calmon MF
Biomed Pharmacother; 2020 Mar; 123():109794. PubMed ID: 31874443
[TBL] [Abstract] [Full Text] [Related]
13. Eribulin penetrates brain tumor tissue and prolongs survival of mice harboring intracerebral glioblastoma xenografts.
Takahashi M; Miki S; Fujimoto K; Fukuoka K; Matsushita Y; Maida Y; Yasukawa M; Hayashi M; Shinkyo R; Kikuchi K; Mukasa A; Nishikawa R; Tamura K; Narita Y; Hamada A; Masutomi K; Ichimura K
Cancer Sci; 2019 Jul; 110(7):2247-2257. PubMed ID: 31099446
[TBL] [Abstract] [Full Text] [Related]
14. The tert locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract] [Full Text] [Related]
15. Brain Distribution and Active Efflux of Three panRAF Inhibitors: Considerations in the treatment of Melanoma Brain Metastases.
Gampa G; Kim M; Mohammad AS; Parrish KE; Mladek AC; Sarkaria JN; Elmquist WF
J Pharmacol Exp Ther; 2019 Mar; 368(3):446-461. PubMed ID: 30622172
[TBL] [Abstract] [Full Text] [Related]
16. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
[TBL] [Abstract] [Full Text] [Related]
17. Genomic Profile of Urothelial Carcinoma of the Upper Tract from Ureteroscopic Biopsy: Feasibility and Validation Using Matched Radical Nephroureterectomy Specimens.
Bagrodia A; Audenet F; Pietzak EJ; Kim K; Murray KS; Cha EK; Sfakianos JP; Iyer G; Singla N; Arcila M; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
Eur Urol Focus; 2019 May; 5(3):365-368. PubMed ID: 29396293
[TBL] [Abstract] [Full Text] [Related]
18. [A long-term follow-up report of pediatric relapsed Wilms tumor after retreatment].
Wang TY; Pan C; Gao YJ; Hu WT; Ye QD; Zhou M; Tang JY
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):743-747. PubMed ID: 29050111
[No Abstract] [Full Text] [Related]
19. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract] [Full Text] [Related]
20. Nephron sparing surgery for renal cell carcinoma up to 7 cm in the context of guideline development: a contribution of healthcare research.
Lebentrau S; Rauter S; Baumunk D; Christoph F; König F; May M; Schostak M
World J Urol; 2017 May; 35(5):753-759. PubMed ID: 27520385
[TBL] [Abstract] [Full Text] [Related]
[Next]
